Jaysynth Orgochem Limited has informed BSE Limited of its upcoming 02/2026-27 Board Meeting, scheduled to be held on Wednesday, May 27, 2026. The meeting will be convened pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The primary agenda is to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.

Board Meeting Details

The following table summarises the key details of the scheduled board meeting:

Trading Window Closure

In accordance with the Code of Practices and Procedures for Fair Disclosures and Conduct, and pursuant to the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, the company had earlier communicated the closure of the trading window. The key dates related to the trading window are outlined below:

The trading window closure applies to dealings in the equity shares of the company by designated persons and their immediate relatives, as mandated under applicable SEBI regulations. The window will remain closed for 48 hours after the declaration of the financial results, consistent with regulatory requirements.

Regulatory Communication

The intimation was filed on May 18, 2026, and addressed to the Corporate Relationship Department of BSE Limited. The notice was signed by Riddhi Kunal Saraiya, Company Secretary and Compliance Officer (Membership No. A50707), on behalf of Jaysynth Orgochem Limited.

Jaysynth Orgochem Limited has submitted a regulatory disclosure to BSE Limited confirming its non-applicability as a Large Corporate under Securities and Exchange Board of India (SEBI) regulations. The disclosure, dated April 16, 2026, addresses compliance requirements under SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018.

Company's Regulatory Status

The company has formally confirmed that it does not meet the applicability criteria for Large Corporate classification as specified in the SEBI circular. This determination is based on the company's financial position and borrowing levels as of the specified reporting date.

Financial Position Details

The disclosure reveals key financial information about the company's borrowing status:

The company reported zero outstanding borrowings as of March 31, 2026, which is a significant factor in determining its non-qualification as a Large Corporate under the SEBI framework.

Regulatory Compliance Framework

Under the SEBI circular, entities identified as Large Corporates are subject to specific borrowing requirements through debt securities. The regulations stipulate that beginning from FY2022, any shortfall in mandatory borrowing through debt securities would attract a fine of 0.20% of the shortfall amount, levied by stock exchanges at the end of the two-year block period.

Since Jaysynth Orgochem Limited does not qualify as a Large Corporate, these mandatory borrowing requirements and associated penalty provisions are not applicable to the company.

Official Authorization

The disclosure was officially signed by two key executives of the company:

• Riddhi Kunal Saraiya - Company Secretary and Compliance Officer
• Mangesh Narayan Patil - Chief Financial Officer

Both officials can be reached at contact number 022 4938 4200/4300 for any regulatory or compliance-related queries.

Implications for Stakeholders

This confirmation provides clarity to investors and stakeholders regarding the company's regulatory status and compliance obligations. The zero borrowing position indicates a debt-free status as of March 31, 2026, which may be viewed favorably by investors seeking companies with strong balance sheet positions.

The disclosure ensures transparency in regulatory compliance and helps maintain the company's good standing with stock exchange requirements and SEBI regulations.